Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jean Jacques Bienaime | Director | 2025-06-03 | 5,000 | $9.38 | $46.90kBuy |
Jack Higgins | Chief Scientific Officer | 2025-03-27 | 5,200 | $1.35 | $7.02kBuy |
Clay B. Siegall | President and CEO | 2025-03-26 | 137,100 | $7.29 | $999.46kBuy |
Jean Jacques Bienaime | Director | 2025-03-25 | 7,800 | $7.78 | $60.68kBuy |
Jean Jacques Bienaime | Director | 2025-03-24 | 7,000 | $8.21 | $57.47kBuy |
Philip Tsai | Chief Technology Officer | 2025-03-24 | 12,300 | $8.42 | $103.57kBuy |
Clay B. Siegall | President and CEO | 2025-01-31 | 150,000 | $7.75 | $1.16MBuy |
Clay B. Siegall | President and CEO | 2024-11-22 | 33,943 | $9.78 | $331.93kBuy |
Clay B. Siegall | President and CEO | 2024-11-21 | 66,057 | $9.54 | $630.25kBuy |
Robert Lechleider | Chief Medical Officer | 2024-11-21 | 15,805 | $9.48 | $149.80kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
T Rowe Price Investment Management Inc | 9.51% | 8,275,257 | $81.10M | Institution |
Fmr LLC | 7.09% | 6,167,666 | $60.44M | Institution |
Blackrock Inc | 6.63% | 5,770,692 | $56.55M | Institution |
Redmile Group LLC | 5.60% | 4,872,225 | $47.75M | Institution |
Enavate Sciences GP LLC | 5.48% | 4,768,583 | $46.73M | Institution |
Point72 Asset Management LP | 5.38% | 4,685,803 | $45.92M | Institution |
Vanguard Group Inc | 5.20% | 4,524,952 | $44.34M | Institution |
Ecor1 Capital LLC | 4.69% | 4,079,415 | $39.98M | Institution |
Opaleye Management Inc | 4.05% | 3,529,581 | $34.59M | Institution |
Primecap Management Co | 3.47% | 3,020,210 | $29.60M | Institution |